Health Invest Partners Ab Harmony Biosciences Holdings, Inc. Transaction History

Health Invest Partners Ab

$221 Million
Q2 2025

A detailed history of Health Invest Partners Ab transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 86,274 shares of HRMY stock, worth $3.17 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

86,274

Previous 91,301 5.51%

Holding current value

$3.17 Million

Previous $3.03 Million 10.03%

% of portfolio

1.23%

Previous 1.41%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	SELL	$27.94 - $35.91 $140,454 - $180,519	-5,027 Reduced 5.51%	86,274 $2.73 Million
Q1 2025 May 05, 2025	SELL	$32.18 - $40.46 $939,656 - $1.18 Million	-29,200 Reduced 24.23%	91,301 $3.03 Million
Q4 2024 Feb 04, 2025	SELL	$31.86 - $41.49 $999,575 - $1.3 Million	-31,374 Reduced 20.66%	120,501 $4.15 Million
Q3 2024 Nov 12, 2024	BUY	$30.0 - $39.95 $3.51 Million - $4.67 Million	116,975 Added 335.17%	151,875 $6.07 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $3.89 Million - $4.46 Million	-135,100 Reduced 79.47%	34,900 $1.05 Million
Q1 2024 Apr 25, 2024	BUY	$29.93 - $35.06 $748,250 - $876,500	25,000 Added 17.24%	170,000 $5.71 Million
Q4 2023 Jan 30, 2024	BUY	$19.2 - $33.78 $2.78 Million - $4.9 Million	145,000 New	145,000 $4.68 Million
Q2 2022 Jul 08, 2022	SELL	$33.54 - $52.15 $1.48 Million - $2.29 Million	-44,000 Reduced 36.67%	76,000 $3.71 Million
Q1 2022 May 05, 2022	SELL	$33.14 - $51.13 $2.49 Million - $3.83 Million	-75,000 Reduced 38.46%	120,000 $5.84 Million
Q4 2021 Jan 18, 2022	BUY	$34.09 - $43.91 $340,900 - $439,099	10,000 Added 5.41%	195,000 $8.32 Million
Q3 2021 Nov 08, 2021	BUY	$25.68 - $38.61 $4.75 Million - $7.14 Million	185,000 New	185,000 $7.09 Million

Others Institutions Holding HRMY

# of Institutions

280

Shares Held

45M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.17B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.

Account

Health Invest Partners Ab Harmony Biosciences Holdings, Inc. Transaction History